Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucidin vs Bactroban for eradication of nasal MSSA carriage in hemodialysis patients
2015-002223-25Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Staphylococcus aureus infection comparing Fucidin arm with Bactroban arm (2 arms). Primary endpoint: difference in eradication of MSSA carriage. Started Jun 2015; status: completed.
02
Drugs
fusidic acidmupirocin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on 2015-002223-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002223-25.